Press Releases

Dec 18, 2002 Rebroadcast of Hemispherx's December 18, 2002 Conference Call Available On Company's Website or Via Telephone Replay

Dec 17, 2002 Hemispherx Presents New Data from Phase IIB Clinical Trial of RNA-based Ampligen® for Structured Treatment Interruption in HIV at DART Conference

Dec 17, 2002 Hemispherx to Host Conference Call on Recent Presentation at the 2002 DART Conference and Other Recent Developments

Dec 16, 2002 Hemispherx Files New US Patent Application on Immune-Based Alternative Treatment to HIV/AIDS

Dec 09, 2002 HEMISPHERX BIOPHARMA COMPLETES FULL ENROLLMENT OF ITS PHASE III CLINICAL TRIAL FOR CHRONIC FATIGUE SYNDROME (CFS)

Nov 25, 2002 Hemispherx Biopharma Invited to Present New Anti HIV Data at DART Conference: Phase IIB Clinical Trials of Strategic Treatment Intervention

Nov 20, 2002 Hemispherx Biopharma, Inc. Adopts Stockholder Rights Plan

Nov 18, 2002 Hemispherx Biopharma and Sigma-Aldrich Enter Agreement to Produce Hemispherx's RNA-based Ampligen® in U.S.

Nov 15, 2002 Hemispherx Announces Third Quarter Results

Nov 04, 2002 Hemispherx Biopharma RNA Drug Technology Targets New Molecular Defects Uncovered in Prostate Cancer

64 65 66 67 68 69 70 71 72 73

<< < > >>